Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Navigating the new sales terrain

This article was originally published in Clinica

Executive Summary

While the recession has resulted in healthcare customers having to face shrinking budgets and delaying purchasing decisions, medical industry sales teams are still charged with maintaining profitability and growth of their companies. What sales strategies and techniques work in an economy facing the most unsettling conditions in decades? How can companies increase sales effectiveness without adding headcount? In this article, the first in a two-part series, Connie Mardis, director of global marketing education at Siemens Healthcare Diagnostics, and Chris Mitchell, director of global accounts at sales and service performance specialist Huthwaite, examine the feasibility of traditional sales methods in today’s economy and explore new strategies that have proven successful

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel